• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[神经病学科中患病率、发病率及神经性疼痛特征的流行病学研究。PREVADOL研究]

[Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. PREVADOL study].

作者信息

Montero Homs J, Gutiérrez-Rivas E, Pardo Fernández J, Navarro Darder C

机构信息

Hospital Bellvitge, Barcelona.

出版信息

Neurologia. 2005 Oct;20(8):385-9.

PMID:16217686
Abstract

INTRODUCTION

Neuropathic pain is defined as a pain initiated or caused by a lesion or dysfunction in the nervous system. The objectives of the study were to estimate the prevalence and incidence of neuropathic pain in hospital neurology units and primary care centres, to characterize the clinical profile of the patient with neuropathic pain and to know the most frequent treatments in the pharmacological management of this type of pain.

METHODS

Observational, cross-sectional epidemiological survey carried out in 36 Neurology Units of the national territory (24 primary care centres and 12 hospitals). During 20 consecutive days neurologists collected the diagnoses of all the attended patients by any reason, up to 30 patients/day. In parallel the 20 first consecutive patients with neuropathic pain were chosen for their characterization in depth by means of a specific questionnaire.

RESULTS

A total of 12,688 patients were attended and a total of 13,555 diagnoses were collected through 713 consultation days. The most frequent diagnosis was migraine/cephalea, with a prevalence of 23.40% (95% CI: 22.66%-24.14%). Neuropathic pain represented the eighth more frequent diagnosis, with a prevalence in neurology units of 3.88% (95% CI: 3.54%- 4.22%). The prevalence of neuropathic pain was 2.92% in primary care centres and 6.09% in hospital units (p < 0.01). The daily incidence of new neuropathic pain cases was 1.24% (95% CI: 1.05%-1.53%); 1.14% in primary care neurology centres and 1.45% in hospital units.

CONCLUSIONS

The data obtained indicate that neuropathic pain is the eighth more frequent diagnosis in the neurology units. Medical assistance request by neuropathic pain is higher in the hospital units.

摘要

引言

神经性疼痛被定义为由神经系统的损伤或功能障碍引发或导致的疼痛。本研究的目的是估计医院神经科病房和初级保健中心神经性疼痛的患病率和发病率,描述神经性疼痛患者的临床特征,并了解这类疼痛药物治疗中最常用的疗法。

方法

在全国36个神经科病房(24个初级保健中心和12家医院)开展观察性横断面流行病学调查。在连续20天里,神经科医生收集所有因任何原因就诊患者的诊断信息,每天最多收集30例患者。同时,选取连续就诊的20例首发性神经性疼痛患者,通过特定问卷进行深入特征分析。

结果

共诊治12,688例患者,通过713个会诊日共收集到13,555份诊断信息。最常见的诊断是偏头痛/头痛,患病率为23.40%(95%置信区间:22.66%-24.14%)。神经性疼痛是第八常见的诊断,在神经科病房的患病率为3.88%(95%置信区间:3.54%-4.22%)。初级保健中心神经性疼痛的患病率为2.92%,医院病房为6.09%(p<0.01)。新发性神经性疼痛病例的每日发病率为1.24%(95%置信区间:1.05%-1.53%);初级保健神经科中心为1.14%,医院病房为1.45%。

结论

所获数据表明神经性疼痛是神经科病房第八常见的诊断。医院病房因神经性疼痛寻求医疗救助的情况更多。

相似文献

1
[Epidemiological study of prevalence, incidence and neuropathic pain characterization in neurology units. PREVADOL study].[神经病学科中患病率、发病率及神经性疼痛特征的流行病学研究。PREVADOL研究]
Neurologia. 2005 Oct;20(8):385-9.
2
[Treatment of neuropathic pain in neurology units. The PREVADOL study].[神经病学单元中神经性疼痛的治疗。PREVADOL研究]
Rev Neurol. 2006;42(8):451-4.
3
[Neuropathic pain as the reason for visiting Neurology: an analysis of its frequency].[将神经病理性疼痛作为就诊于神经科的原因:其发生率分析]
Rev Neurol. 2005;41(11):643-8.
4
Prevalence, etiology, and management of neuropathic pain in an Indian cancer hospital.一家印度癌症医院中神经性疼痛的患病率、病因及管理
J Pain Palliat Care Pharmacother. 2009;23(2):114-9. doi: 10.1080/15360280902900489.
5
Modelling the prevalence and cost of back pain with neuropathic components in the general population.在普通人群中建模具有神经性成分的背痛的流行率和成本。
Eur J Pain. 2009 Nov;13(10):1030-5. doi: 10.1016/j.ejpain.2008.12.003. Epub 2009 Feb 6.
6
Preliminary evaluation of the Health Background Questionnaire for Pain and clinical encounter form for pain.疼痛健康背景调查问卷及疼痛临床问诊表的初步评估。
Pain Med. 2005 Nov-Dec;6(6):443-51. doi: 10.1111/j.1526-4637.2005.00075.x.
7
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.疼痛检测问卷(painDETECT):一种用于识别背痛患者神经病理性成分的新型筛查问卷。
Curr Med Res Opin. 2006 Oct;22(10):1911-20. doi: 10.1185/030079906X132488.
8
A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery.一项调查胸外科手术后慢性疼痛的神经病理性成分患病率的问卷调查研究。
Eur J Cardiothorac Surg. 2006 May;29(5):800-5. doi: 10.1016/j.ejcts.2006.02.002. Epub 2006 Apr 3.
9
[An analysis of avoidable admissions to a neurology service].[对神经内科可避免入院情况的分析]
Rev Neurol. 2006;43(12):714-8.
10
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).与神经或躯体损伤相关的疼痛综合征比较及新型神经性疼痛诊断问卷(DN4)的编制
Pain. 2005 Mar;114(1-2):29-36. doi: 10.1016/j.pain.2004.12.010. Epub 2005 Jan 26.

引用本文的文献

1
NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities.神经病理性疼痛中的神经生长因子:了解其作用及治疗机会
Curr Issues Mol Biol. 2025 Jan 31;47(2):93. doi: 10.3390/cimb47020093.
2
In Vitro and In Vivo Effects of Flavonoids on Peripheral Neuropathic Pain.黄酮类化合物对周围神经性疼痛的体外和体内作用。
Molecules. 2020 Mar 5;25(5):1171. doi: 10.3390/molecules25051171.
3
Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life.
西班牙疼痛门诊患者中枢性和周围神经性疼痛的患病率:与疼痛强度和生活质量相关的因素
J Pain Res. 2018 Sep 12;11:1835-1847. doi: 10.2147/JPR.S159729. eCollection 2018.
4
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.普瑞巴林或加巴喷丁在常规临床实践中治疗周围神经性疼痛的成本:专利独占权丧失的影响
J Eval Clin Pract. 2017 Apr;23(2):402-412. doi: 10.1111/jep.12634. Epub 2016 Sep 27.
5
Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health.癌症相关性神经病理性疼痛患者接受普瑞巴林与非普瑞巴林治疗的事后分析:更好的疼痛缓解、睡眠和身体健康。
Clin Transl Oncol. 2011 Sep;13(9):656-63. doi: 10.1007/s12094-011-0711-0.
6
The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.神经病理性疼痛的流行率:社区人群中临床评估与筛查工具的比较。
Pain Med. 2009 Apr;10(3):586-93. doi: 10.1111/j.1526-4637.2009.00588.x. Epub 2009 Mar 17.
7
Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study.西班牙初级保健机构中神经性疼痛的患病率及特征:一项横断面、多中心观察性研究
Clin Drug Investig. 2009;29(7):441-450. doi: 10.2165/00044011-200929070-00002.
8
[Neuropathic pain among hospital in-patients. Analysis of Austrian hospital discharge data].[住院患者中的神经性疼痛。奥地利医院出院数据分析]
Schmerz. 2009 Feb;23(1):59-64. doi: 10.1007/s00482-008-0728-7.
9
A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study.疼痛诊所神经性疼痛的病因及成本登记:神经性疼痛疾病病因与成本登记(REC)研究结果
Clin Drug Investig. 2007;27(11):771-82. doi: 10.2165/00044011-200727110-00004.